NEW YORK, August 12, 2026, 18:50 EDT
NANO Nuclear Energy Inc. NASDAQ:NNE reported just $214,042 of fiscal third-quarter revenue. Yet it ended June with $580.6 million of cash and liquid investments. That contrast now defines the stock.
At Wednesday’s $19.01 close, NANO Nuclear’s equity was worth about $1.02 billion. Liquid assets covered roughly 57% of that value. Investors therefore assigned about $440 million to the reactor program, acquired operations and other assets beyond liquidity.
The shares fell 1.91% in regular trading. They recovered 0.79% to $19.1606 after hours by 18:39 EDT. Volume was 2.49 million shares, slightly below the 2.62 million average.
| Trading measure | August 12 value | Investor read-through |
|---|---|---|
| Regular close | $19.01 | Down 1.91% |
| After-hours price | $19.1606 | Up 0.79% from close |
| Session range | $18.85-$19.96 | 5.8% intraday span |
| 52-week range | $14.71-$60.87 | Close was 69% below high |
The June-quarter filing recorded NANO Nuclear’s first consolidated revenue. Secured Transportation Services contributed after its May 22 acquisition. The subsidiary had produced $3.9 million of unaudited revenue during the first half, but only the post-acquisition period entered NANO Nuclear’s accounts.
That short stub generated $62,211 of gross profit, a 29.1% margin. Scale remains tiny beside the development budget. Operating expenses reached $15.9 million, led by $11.9 million of general costs.
| Quarter ended June 30 | 2026 | 2025 | Change |
|---|---|---|---|
| Revenue | $0.21 million | $0 | First reported revenue |
| Gross profit | $0.06 million | $0 | 29.1% margin |
| Operating loss | $15.83 million | $9.39 million | Loss widened 68% |
| Net loss | $10.10 million | $7.59 million | Loss widened 33% |
| Loss per share | $0.19 | $0.19 | Unchanged |
The unchanged per-share loss needs context. Weighted-average shares rose 34% from a year earlier. That increase offset the larger net loss in the EPS calculation.
NANO Nuclear’s balance sheet remains the main buffer. Cash, short-term investments and marketable securities totaled $580.6 million, or $10.81 per outstanding share. Book value was $11.47 per share.
| Valuation bridge | Total | Per share | Share of market value |
|---|---|---|---|
| Cash and liquid investments | $580.6 million | $10.81 | 56.9% |
| Implied value above liquidity | $440.2 million | $8.20 | 43.1% |
| Stockholders’ equity | $616.0 million | $11.47 | 60.3% |
| Equity market value | $1.021 billion | $19.01 | 100% |
The company used $18.7 million in operating cash over nine months. It raised $411.5 million through financing activities, including a private placement and its at-the-market program. The financing base, not operating revenue, funded expansion.
| Nine-month capital measure | 2026 | 2025 | Change |
|---|---|---|---|
| Operating cash used | $18.66 million | $14.71 million | 27% more |
| Financing cash provided | $411.50 million | $209.27 million | 97% more |
| Quarter-end shares outstanding | 53.70 million | 41.54 million | 29% more |
Regulatory progress supports part of the premium. The Nuclear Regulatory Commission accepted the KRONOS MMR construction-permit application for formal review. The company expects environmental and safety reviews during 2027, with construction potentially starting in the second half. Those dates remain subject to approval.
NANO Nuclear also cited discussions covering several gigawatts of possible data-center demand. It has not announced firm reactor sales from that pipeline. Chief Executive James Walker said liquidity “continues to be a significant strategic advantage.” Company results release
Wall Street remains constructive, though coverage is thin. MarketBeat counted eight current ratings through July 28. Its $40.75 average target implied 114% upside from Wednesday’s close, but those targets preceded the quarter’s filing.
| Analyst recommendation | Count | Share of ratings |
|---|---|---|
| Strong buy | 1 | 12.5% |
| Buy | 4 | 50.0% |
| Hold | 2 | 25.0% |
| Sell | 1 | 12.5% |
| Consensus | 8 | Moderate Buy |
The week ahead will test whether investors emphasize the cash cushion or the revenue gap. The webcast replay, STS integration details and any binding customer agreements are the clearest checkpoints.
Risks: NANO Nuclear has no commercial reactor in operation. Licensing delays, higher development costs and more share issuance could erode the liquidity backing. The new logistics unit also carries integration risk.
Related articles: NASDAQ:NNE
